NO943008L - Renseblanding for galleveiene - Google Patents

Renseblanding for galleveiene

Info

Publication number
NO943008L
NO943008L NO943008A NO943008A NO943008L NO 943008 L NO943008 L NO 943008L NO 943008 A NO943008 A NO 943008A NO 943008 A NO943008 A NO 943008A NO 943008 L NO943008 L NO 943008L
Authority
NO
Norway
Prior art keywords
bile ducts
purification mixture
purification
mixture
bile
Prior art date
Application number
NO943008A
Other languages
English (en)
Other versions
NO943008D0 (no
Inventor
Akihito Moriyasu
Original Assignee
Senju Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharma Co filed Critical Senju Pharma Co
Publication of NO943008D0 publication Critical patent/NO943008D0/no
Publication of NO943008L publication Critical patent/NO943008L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Detergent Compositions (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Et rensepreparat for galleveiene som omfatter fra ca. 10% vekt/volum til ca. 40% vekt/volum N-acetylcystein eller et alkalimetallsalt derav som aktiv bestanddel, i en vandig opplesning regulert til en pH-verdi på 7,0 til 8,0.
NO943008A 1993-08-16 1994-08-15 Renseblanding for galleveiene NO943008L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP23598693 1993-08-16

Publications (2)

Publication Number Publication Date
NO943008D0 NO943008D0 (no) 1994-08-15
NO943008L true NO943008L (no) 1995-02-17

Family

ID=16994125

Family Applications (1)

Application Number Title Priority Date Filing Date
NO943008A NO943008L (no) 1993-08-16 1994-08-15 Renseblanding for galleveiene

Country Status (7)

Country Link
EP (1) EP0639375A1 (no)
KR (1) KR950005304A (no)
AU (1) AU7024094A (no)
CA (1) CA2130132A1 (no)
FI (1) FI943748A (no)
NO (1) NO943008L (no)
RU (1) RU94029670A (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2011202871B2 (en) * 2005-08-24 2014-06-12 Cumberland Pharmaceuticals Inc. Acetylcysteine composition and uses therefor
US8148356B2 (en) 2005-08-24 2012-04-03 Cumberland Pharmaceuticals, Inc. Acetylcysteine composition and uses therefor

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69209335T2 (de) * 1991-01-26 1996-08-29 Senju Pharma Co Mittel zur Zersetzung von Gallensteinen

Also Published As

Publication number Publication date
AU7024094A (en) 1995-02-23
NO943008D0 (no) 1994-08-15
EP0639375A1 (en) 1995-02-22
KR950005304A (ko) 1995-03-20
CA2130132A1 (en) 1995-02-17
RU94029670A (ru) 1996-08-27
FI943748A0 (fi) 1994-08-15
FI943748A (fi) 1995-02-17

Similar Documents

Publication Publication Date Title
BR9713465A (pt) Inibidores metalotprotease de amina cìclica sibstituìda
FI942423A0 (fi) Sakkariinijohdannisia proteolyyttisen entsyymin inhibiittoreina
HRP20020198B1 (en) Moxifloxacin formulation containing common salt
ES2182852T3 (es) Derivados de prolinamida.
TR200001645T2 (tr) Retinoyik asit taklidi anilürler.
CA2244785A1 (en) Pentafluorobenzenesulfonamides and analogs
AU4384397A (en) Benzamidine derivatives substituted by cyclic amino acid and cyclic hydroxy acid derivatives and their use as anti-coagulants
AU5453894A (en) Antibacterial mouthwash
NO954072D0 (no) Vannopplöselige camptotecinderivater, fremgangsmåte for deres fremstilling og deres anvendelse som antitumormidler
AU4095689A (en) Washing and cleaning agents
DK0888271T3 (da) Benzamidinderivater substitueret med aminosyre- og hydroxysyrederivater og deres anvendelse som antikoagulerende midler
HUP0003571A2 (hu) 6,9-Hídkötésű eritromicin-származékok
AU2658695A (en) N-(3-amino-2-hydroxybutyl)sulphonamide derivatives as hiv protease inhibitors
BR0304298A (pt) Composição contendo um ácido orgânico cosmeticamente ativo e um produto de legume
ES2132383T3 (es) Inhibidores de proteasa hiv.
NO943008L (no) Renseblanding for galleveiene
DK0875248T3 (da) Anvendelse af hyaluronsyre og korresponderende salte til fremstilling af en vandig opløsning, der er velegnet som intra-artikulær skyllevæske
DK0773782T3 (da) Terpenderivater (sarcodictyiner) anvendelse som antitumormidler
ES2129135T3 (es) Composiciones limpiadoras que contienen un alcanoato como acondicionador.
SE9604582D0 (sv) Novel compounds
KR970704456A (ko) 인터류킨 5 생성 억제제(Interleukin 5 Production Inhibitor)
AU7470098A (en) Antithrombotic agents
WO1996028151A3 (en) Use of a pyruvate dehydrogenase activator for the treatment of ischaemia in limbs
PE20000271A1 (es) Composicion farmaceutica de (1s,4r)-cis-4-[2-amino-6-(ciclopropilamino)-9h-purin-9-il]-2-ciclopenteno-1-metanol
AU7028798A (en) Use of 2-methylthiazolidine-2,4-dicarboxylic acid as mucolytic agent